Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES
Parakkal Deepak(Washington University in St. Louis), Alfred H.J. Kim(Unknown), Rebecca E. Schriefer, Jane A. O’Halloran(St. Vincent's University Hospital), Wooseob Kim(Korea University), Emanuel Demissie(University of California, San Francisco), Alem Haile(Washington University in St. Louis), Salim Chahin(Washington University in St. Louis), Sewuese E. Akuse, Mehrdad Matloubian(University of California, San Francisco), Lily E. McMorrow, Alia A. El‐Qunni, Ali H. Ellebedy(Washington University in St. Louis), Mary C. Nakamura(University of California, San Francisco), Matthew A. Ciorba, Billy D. Nix, Lianne S. Gensler(University of California, San Francisco), Shannon E. Sides(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), M Gergely, Samantha Burdess(Washington University in St. Louis), Dana C. Perantie, Patricia Katz(University of California, San Francisco), Jonathan Graf(University of California, San Francisco), Gregory F. Wu(University of Pennsylvania), Mahima Thapa(Washington University in St. Louis), Lynne M. Mitchell, Guadalupe Oliva Escudero, Niti Pawar(University of California, San Francisco), Michael K. Klebert(Washington University in St. Louis), Katherine Huang(Broad Institute), Alexander Carvidi(University of California, San Francisco), Diana Páez, Monica Yang, Michael Paley
Cited by 0